Lifeward Ltd. Files 8-K

Ticker: LFWD · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1607962

Sentiment: neutral

Topics: corporate-event, filing, financial-reporting

TL;DR

Lifeward Ltd. (ex-ReWalk) filed an 8-K on 4/15/25. Nothing major, just corporate housekeeping.

AI Summary

Lifeward Ltd. (formerly ReWalk Robotics Ltd.) filed an 8-K on April 15, 2025, reporting other events and financial statements. The company, incorporated in Israel, has its principal executive offices at 200 Donald Lynch Blvd., Marlborough, MA. It was formerly known as Argo Medical Technologies Ltd. prior to a name change on May 13, 2014.

Why It Matters

This 8-K filing indicates a routine update from Lifeward Ltd. regarding its corporate events and financial reporting, providing transparency to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for other events and financial statements, not indicating any immediate material changes or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Lifeward Ltd.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 15, 2025.

What were Lifeward Ltd.'s previous names?

Lifeward Ltd. was formerly known as ReWalk Robotics Ltd. and prior to that, Argo Medical Technologies Ltd.

When did Lifeward Ltd. change its name from Argo Medical Technologies Ltd.?

The name change from Argo Medical Technologies Ltd. to Lifeward Ltd. occurred on May 13, 2014.

Where are Lifeward Ltd.'s principal executive offices located?

Lifeward Ltd.'s principal executive offices are located at 200 Donald Lynch Blvd., Marlborough, MA 01752.

What is Lifeward Ltd.'s SIC code and industry?

Lifeward Ltd.'s Standard Industrial Classification (SIC) code is 3842, which falls under 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Lifeward Ltd. (LFWD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing